Summary of the latest safety advice for medicines and medical device users
Similar Posts
Medicines: Marketing Authorisation Holders’ submission of Nitrosamine risk evaluation, risk assessment and confirmatory testing
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
Field Safety Notices: 09-13 February 2026
A list of Field Safety Notices: 09-13 February 2026
Decision: Advertising Investigations: October 2025
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
Medicines marketing authorisation: change of ownership
How to change the ownership from one marketing authorisation (MA) holder to another.
Guidance: CLOSED AI Airlock Phase 2 application
The call for applications for phase 2 of the AI Airlock is now closed.
Field Safety Notices: 22-26 December 2025
List of Field Safety Notices for 22-26 December 2025